1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NTSR1 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA TRIP6 CTRPv2 pan-cancer AAC 0.098 0.01
mRNA TBC1D25 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA RNF43 CTRPv2 pan-cancer AAC 0.11 0.01
mRNA PTPN22 CTRPv2 pan-cancer AAC -0.11 0.01
mRNA SUSD3 CTRPv2 pan-cancer AAC -0.097 0.01
mRNA RP11-87C12.2 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA TSPYL2 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA CD79B CTRPv2 pan-cancer AAC -0.097 0.01
mRNA SCLY CTRPv2 pan-cancer AAC 0.09 0.01
Download CSV